WOBURN, Mass., May 3, 2024 /PRNewswire/ -- Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.
The agreement combines the Laminar flow-based gentle liquid exchange technology known as C-FREE™ technology from Curiox with the comprehensive suite of DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails from Beckman Coulter Life Sciences. This workflow solution overcomes longstanding challenges faced by researchers worldwide, including the need for highly standardized, reproducible, and automated sample preparation for flow cytometry laboratories.
"Our alliance with Beckman Coulter Life Sciences is not just about combining technologies; it's about combining our strengths to empower the scientific community," said Namyong Kim. PhD, CEO of Curiox Biosystems. "By addressing the challenges of standardization, automation, and reproducibility head-on, we are paving the way for significant advancements in research and healthcare."
"Speed and accuracy are of the utmost importance in delivering results to researchers to enable them to make critical decisions on their journey to pioneering new discoveries," said Pietro Lopriore, Vice President and General Manager of Flow Cytometry at Beckman Coulter Life Sciences. "This partnership presents an exciting step forward in redefining the standards of quality and efficiency in flow cytometry research. By being a trusted partner to the scientific community, we're able to combine complementary technologies to unite in a common goal of advancing research to positively impact lives."
This partnership is expected to accelerate the research and development of next-generation therapies, vaccines, and biomanufacturing processes.
About Curiox Biosystems Co. Ltd
Curiox Biosystems Co. Ltd is a rapidly growing global biotechnology company specializing in advanced sample preparation solutions that enhance next-generation therapies. The company leverages expertise in surface chemistry and instrumentation to address life-science research challenges, particularly in miniaturization and automation. Curiox's innovative technologies boost productivity through sample preparation automation, speeding up therapeutic development. Committed to advancing its proprietary C-FREE™ technology, Curiox enables significant scientific breakthroughs, reinforcing its role as a key player in transforming life sciences research and diagnostics worldwide. Visit us at https://www.curiox.com/
About Beckman Coulter Life Sciences
With a relentless mission to empower those seeking answers to life's important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, our technologies reduce manual laboratory processes and can provide greater speed, accuracy, and advanced analytics to accelerate answers with a guiding focus to improve patient care and enable pioneering discoveries. Beckman Coulter Life Sciences, part of the Danaher Corporation (NYSE: DHR) family of global science and technology companies, is headquartered in Indianapolis, Indiana with 11 operational hubs around the world and employs approximately 2,800 associates with more than 400,000 systems installed globally. Get to know us by clicking here and by following us on LinkedIn.
Contact Information:
For Curiox Biosystems Co. Ltd:
Attn: Mahrukh M Banday, EVP/GM
This email address is being protected from spambots. You need JavaScript enabled to view it.
USA: 400 W Cummings Park #6650, Woburn, MA 01801
Corporate office
#212 Samsung Harrington IT Tower, 9 Gil 41 Digital-Ro, Geumchun-Gu, Seoul 08511, Korea
For Beckman Coulter Life Sciences:
Matt McCutcheon, Global External Communications Manager
(317) 719-0557 or This email address is being protected from spambots. You need JavaScript enabled to view it.
For Research Use Only (RUO). Not for use in diagnostic procedures.
Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.
Last Trade: | US$245.66 |
Daily Change: | 3.34 1.38 |
Daily Volume: | 4,031,874 |
Market Cap: | US$177.420B |
October 22, 2024 September 17, 2024 July 23, 2024 July 17, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB